Avecho Biotechnology Ltd has released a press release.
Phosphagenics Update on TPM/Propofol Development Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Phosphagenics Entitlement Offer Information Booklet
- Phosphagenics Announces Equity Raising
- Phosphagenics Signs Term Sheet TPM Diclofenac Gel in Asia
- Phosphagenics Market Update - Potential Return of Capital
- June 2017 Half-year Financial Report and Appendix 4D
Later from Avecho Biotechnology
- Phosphagenics Multinational License for TPM in Personal Care
- TPM Improves Negative Effects of Heat Stress in Poultry
- Phosphagenics Announces Results of Dairy Trial
- Phosphagenics Receipt of R&D Tax Incentive
- Phosphagenics Placement Secures A$1.37 million
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology